270 related articles for article (PubMed ID: 22195409)
1. Pathology and genetics of meningiomas.
Alahmadi H; Croul SE
Semin Diagn Pathol; 2011 Nov; 28(4):314-24. PubMed ID: 22195409
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
4. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
Dezamis E; Sanson M
Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
[TBL] [Abstract][Full Text] [Related]
6. Pathological classification and molecular genetics of meningiomas.
Mawrin C; Perry A
J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
[TBL] [Abstract][Full Text] [Related]
7. Genetic changes with prognostic value in histologically benign meningiomas.
Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
9. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
10. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
[TBL] [Abstract][Full Text] [Related]
12. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations.
Ely EE; Guzman MA; Calvey LS; Batanian JR
Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240
[TBL] [Abstract][Full Text] [Related]
13. [Meningioma. Classification and grading].
Niedermayer I; Kolles H; Henn W; Zang KD; Steudel WI; Feiden W
Pathologe; 1997 Sep; 18(5):353-8. PubMed ID: 9432670
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
15. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas.
Boström J; Mühlbauer A; Reifenberger G
Acta Neuropathol; 1997 Nov; 94(5):479-85. PubMed ID: 9386781
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
18. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
[TBL] [Abstract][Full Text] [Related]
19. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
20. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
